**Core tip:** We present 3 cases of malignant small bowel obstruction, treated with palliative care using endoscopic self-expandable metallic stent (SEMS) placement, and have identified that the procedure is safe and effective. Two patients were treated using the through-the-overtube technique, while the remaining case was the first case of SEMS placement in a malignant distal small bowel obstruction.

INTRODUCTION
============

Malignant small bowel obstructions are primarily treated with surgical intervention. However, palliative surgery is highly invasive in such patients, with poor prognosis; therefore, minimally invasive therapies, such as the endoscopic placement of self-expandable metallic stents (SEMS), have been considered. SEMS has been used successfully to palliate malignant gastrointestinal obstructions, and is widely reported to result in good clinical outcomes for colonic, esophageal, and gastric obstructions\[[@B1]-[@B4]\]. However, SEMS placement for malignant small bowel obstructions is little-known and also more challenging. A deep small bowel enteroscopy is limited, and three endoscopy systems are now available: \[double balloon endoscopy (DBE), single balloon endoscopy, and spiral endoscopy\[[@B5]-[@B7]\]\]; however, such endoscope systems do not have working channels large enough for the stent delivery systems to pass through. Therefore, the standard through-the-scope (TTS) technique for stent deployment could not be applied. To mitigate this limitation, we modified the standard over-the-guidewire (OTW) technique for stent deployment. In this report, we present 3 cases of malignant small bowel obstruction treated with palliative SEMS placement.

CASE REPORT
===========

Of the 3 patients studied, 1 received stent deployment using the standard TTS technique *via* colonoscopy (CF-H260AI, Olympus, Tokyo, Japan); SEMS placement in the other 2 patients was achieved using the through-the-overtube (TTO) technique *via* DBE (EN450T5/W, FUJIFILM, Tokyo, Japan). The TTO technique is a modified version of the OTW technique. First, the endoscope with the overtube (TS13140, FUJIFILM, Tokyo, Japan), without its balloon tip, was advanced towards the stricture, and a 0.035-inch guidewire (Jagwire, Boston Scientific Corp., Natick, MA, United States) was passed through the stricture. Subsequently, the guidewire and the overtube were left in place, and the endoscope was removed. Finally, the overtube was utilized as a large channel to advance the stent through the stricture over the guidewire under fluoroscopic guidance. All 3 cases were performed by a single expert endoscopist with experience in over 20 cases of colon stenting.

Case 1
------

A 60-year-old woman was admitted to our hospital with abdominal pain due to terminal ileum obstruction because of peritoneal dissemination of pancreatic cancer. Although her symptoms improved after insertion of an ileus tube, they recurred following commencement of oral intake. Consequently, the decision was made to attempt SEMS placement as a palliative therapy. A colonoscope was advanced to the stricture, and the standard TTS technique for stenting with a 10 cm × 20 mm uncovered SEMS (Niti-S biliary stent, TaeWoong Medical, Seoul, South Korea) (Figure [1](#F1){ref-type="fig"}) was used. The patient was discharged 24 d after stenting, and died 109 d after stenting.

![Self-expandable metallic stent deployment using the standard through-the-scope technique under fluoroscopic guidance. A: The scope was advanced to the stricture, and a standard guidewire was passed through the stricture; B: The stent delivery system was advanced through the scope across the stricture; C: The stent can be seen successfully deployed across the stricture.](WJG-22-9022-g001){#F1}

Case 2
------

An 87-year-old woman was admitted to our hospital with anorexia, vomiting, and weight loss. An abdominal computed tomography (CT) scan revealed cancer in the head of the pancreas, a metastatic hepatic tumor, and expansion of the stomach and duodenum. We concluded that the obstruction of the distal duodenum/angle of Treitz was secondary to pancreatic cancer invasion. We attempted advancement of a colonoscope (CF-H260AZI, Olympus, Tokyo, Japan) to the stricture, but could not reach the region as it was too deep, and the endoscope position was tortuous. Subsequently, DBE endoscopy was performed, and access was achieved with a stable endoscope position. Unfortunately, we could not use the TTS technique for stent deployment given the position of the stricture. Therefore, we decided to employ the TTO technique for stenting. An endoscope loaded with a balloon overtube was advanced into the stricture for a trans-oral approach. While the guidewire was left in place beyond the stricture, the endoscope was removed, leaving the overtube in place. A 10 cm × 22 mm stent (Niti-S D pyloric/duodenal stent, TaeWoong Medical, Seoul, South Korea) was advanced using the OTW technique through the overtube, and was deployed successfully (Figure [2](#F2){ref-type="fig"}). The patient was discharged 15 d after the procedure and died 76 d after stenting.

![Self-expandable metallic stent deployment using the through-the-overtube technique under fluoroscopic guidance. A: The DBE was advanced to the stricture, and a standard guidewire passed through the stricture; B: The stent delivery system was advanced over the wire through the overtube; C: The stent deployed across the stricture; D: The overtube was withdrawn.](WJG-22-9022-g002){#F2}

Case 3
------

A 69-year-old woman with Stage IV pancreatic cancer who was receiving chemotherapy was admitted due to abdominal distension and vomiting. Abdominal CT revealed an intestinal stricture secondary to peritoneal dissemination. She was initially treated with ileus tube insertion for the obstruction (due to recurrence), but requested palliative SEMS placement. As we were able to reach the stricture with DBE, we decided to place the SEMS using the TTO technique. The endoscope and overtube were advanced to the stricture *via* the trans-anal approach. The guidewire (Wrangler, PIOLAX medical devices Inc., Kanagawa, Japan) and overtube were left in place while the endoscope was removed. An 8 cm × 18 mm stent (Niti-S D colonic stent, TaeWoong Medical, Seoul, South Korea) was advanced through the overtube, and deployed successfully (Figure [3](#F3){ref-type="fig"}). The patient was discharged on day 12 after the procedure and died of her primary cancer 29 d after stenting.

![Self-expandable metallic stent deployment using the through-the-overtube technique *via* a trans-anal approach under fluoroscopic guidance. A: The DBE was advanced to the stricture, and a guidewire passed through the stricture; B: The guidewire and overtube were left in place and the endoscope was removed; C: The stent delivery system was advanced over the wire through the overtube, and the stent deployed across the stricture; D: The overtube was withdrawn.](WJG-22-9022-g003){#F3}

All 3 patients in our study tolerated clear fluids the day after stenting, followed by a low residue diet. They were all discharged from the hospital at variable times with no major complications following SEMS placement (Table [1](#T1){ref-type="table"}; summary of cases). All stents remained patent until patient death. The technical and clinical success rates were 100%.

###### 

Summary of cases

  **Age/sex**     **Tumor**                  **Stricture location**   **Scope**   **Stent delivery**   **Stricture length**   **Type of stent**      **Procedural time**   **Stent patency time**   **Time to oral intake after stent placement**
  --------------- -------------------------- ------------------------ ----------- -------------------- ---------------------- ---------------------- --------------------- ------------------------ -----------------------------------------------
  60/F            Pancreatic cancer          Terminal ileum           Olympus     TTS                  40 mm                  Niti-S 20 mm × 10 cm   132 min               109 d                    5 d
  Peritoneal      CF-H260A                                                                                                                                                                          
  dissemination                                                                                                                                                                                     
  87/F            Pancreatic cancer          Proximal jejunum         FUJIFILM    TTO                  30 mm                  Niti-S 22 mm × 10 cm   46 min                76 d                     2 d
  EN-450T5/W                                                                                                                                                                                        
  (trans-oral)                                                                                                                                                                                      
                  Pancreatic cancer          Distal ileum             FUJIFILM    TTO                  20 mm                  Niti-S 18 mm × 8 cm    104 min               29 d                     2 d
                  Peritoneal dissemination   EN-450T5/W                                                                                                                                             
  60/F                                       (trans-anal)                                                                                                                                           

TTS: Through-the-scope; TTO: Through-the-overtube.

DISCUSSION
==========

Malignant small bowel obstructions are typically caused by primary small bowel malignant tumors, local invasion of extrinsic malignant tumors, or metastasis\[[@B8]\]. Although surgical interventions such as gastroenteric bypass or ileostomy are considered the primary treatment for patients with malignant small bowel obstructions, they are not routinely performed in view of poor prognoses. Recently, SEMS placement has been used to treat malignant, non-small bowel gastrointestinal obstructions. Compared with surgery, SEMS placement is much less invasive. Good clinical outcomes have been reported in esophageal, gastroduodenal, and colorectal malignant obstructions\[[@B1],[@B9]\]. While the efficacy and safety of palliative SEMS placement in these types of malignant obstructions are well-established, it remains largely unknown how such parameters measure in malignant small bowel obstructions distal to the ligament of Treitz. In this study, the technical and clinical success rates were 100%, with no major complications observed. Therefore, we propose that SEMS placement for malignant small bowel obstruction is equally effective and safe.

SEMS placement for malignant small bowel obstruction is challenging given the difficulty in accessing the site. Jeurnink et al\[[@B10]\] reported that enteral SEMS placement could be effectively and safely performed for malignant obstructions of the distal duodenum or proximal jejunum with colonoscopy. SEMS placement *via* colonoscopy is preferable for treatment of these lesions, considering the scope length and working channel, which is large enough for the standard TTS technique. In case 1, we used a colonoscope to deploy the SEMS with the TTS technique, as the scope could be advanced to the malignant stricture of the terminal ileum; the stenting was performed successfully.

Few reports on SEMS placement for malignant small bowel obstructions have been published. Lee et al\[[@B11]\] reported on 19 patients with malignant small bowel obstructions who underwent SEMS insertion. In these patients, SEMS placement was performed with the withdrawal-reinsertion technique using DBE. In their report, the technical and clinical success rates were 95% and 84%, respectively, and no major complications were observed during the procedures. According to the report, SEMS placement appeared to be effective for palliation of malignant small bowel obstructions. However, patients with malignant distal small bowel obstructions were excluded from the report; therefore, the efficacy and safety of SEMS placement in these regions was largely unknown.

As current enteroscopy systems do not possess working channels large enough for stent delivery systems to pass through, SEMS placement utilizing the TTS technique with an enteroscope is not possible. Therefore, the TTO technique was developed by modifying the OTW technique for SEMS placement in malignant distal small bowel obstructions using DBE. Ross et al\[[@B5]\] reported a case of malignant distal duodenal obstruction treated with SEMS placement using DBE with the TTO technique, similar to case 2 of our study. Lennon et al\[[@B6]\] reported a similar technique using SE. The key to this technique is the ability to reach the stricture and lock the overtube in position at the location; this provides a sheath through which the stent could easily pass the stricture and be deployed. Although this technique can potentially treat deeper malignant small bowel obstructions, the few case reports that are available have only used this technique in the distal duodenum, proximal jejunum, or surgically-reconstructed intestines\[[@B5],[@B6],[@B11]-[@B14]\]. To the best of our knowledge, case 3 of our study is the first case of SEMS placement in a malignant distal small bowel obstruction.

Shimatani et al\[[@B15]\] recently reported on SEMS placement for malignant afferent-loop obstruction using the TTS technique with a new short-type DBE (EI-580 BT; Fujifilm, Tokyo, Japan). As the new short-type DBE has a 3.2-mm working channel, the 9 Fr SEMS delivery system can be used with the TTS technique. We believe that a long-type DBE (also with a 3.2-mm working channel) will be developed in the near future. This will allow treatment of deeper malignant small bowel obstructions with SEMS placement using the TTS technique.

In conclusion, our study revealed that palliative SEMS placement is safe and effective in malignant small bowel obstructions. However, given our small sample size, further studies are warranted. Nevertheless, we believe that SEMS placement will play a significant role in the primary treatment of malignant small bowel obstructions in the near future, with further development of endoscopy and SEMS delivery systems.
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COMMENTS
========

Case characteristics
--------------------

Three patients (a 60-year-old woman, an 87-year-old woman, and a 69-year-old woman) presented with small bowel obstruction due to pancreatic cancer.

Clinical diagnosis
------------------

An abdominal computed tomography (CT) scan revealed the clinical diagnoses in all cases.

Imaging diagnosis
-----------------

Abdominal CT showed small bowel obstruction because of pancreatic cancer.

Treatment
---------

Endoscopic self-expandable metallic stents (SEMS) were placed in each patient.

Related reports
---------------

Only a few reports regarding SEMS placement for malignant small bowel obstructions have been published. Notably, case 3 in this study may be the first reported case of SEMS placement in a malignant distal small bowel obstruction.

Term explanation
----------------

through-the-scope was defined as tube-through-the-scope, over-the-guidewire was defined as over-the-guidewire, and through-the-overtube was defined as through-the-overtube.

Experiences and lessons
-----------------------

The authors present 3 cases of malignant small bowel obstruction that received palliative SEMS placement safely and effectively. The SEMS placement will play a significant role in the primary treatment of malignant small bowel obstruction in the near future, with further development of endoscopy and SEMS delivery systems.

Peer-review
-----------

The authors presented 3 cases of malignant small bowel obstruction treated with palliative care by endoscopic SEMS placement and revealed that the procedure is safe and effective. The findings will be of interest to the readership.
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